D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
CALL
Itaú Unibanco
ITUB
$91.3B
| $343K | ﹤0.01% |
51,537
| – | – |
|
3527
Par Pacific Holdings
PARR
$3.88B
| $343K | ﹤0.01% |
14,780
-497
| -3% | -$11.9K |
|
3528
UDR
UDR
$12.9B
| $342K | ﹤0.01% |
7,333
-42,016
| -85% | -$2.02M |
|
3529
CALL
GoDaddy
GDDY
$12.3B
| $340K | ﹤0.01% |
5,000
| – | – |
|
3530
PUT
HCA Healthcare
HCA
$84.8B
| $340K | ﹤0.01% |
2,300
-3,500
| -60% | -$470K |
|
|
WIRE
3531
DELISTED
Encore Wire Corp
WIRE
| $340K | ﹤0.01% |
5,921
-2,058
| -26% | -$118K |
|
|
OSG
3532
Octave Specialty Group
OSG
$252M
| $339K | ﹤0.01% |
+15,706
| New | +$322K |
|
3533
Franklin Electric
FELE
$4.67B
| $339K | ﹤0.01% |
5,921
-15,595
| -72% | -$824K |
|
3534
Amphenol
APH
$188B
| $337K | ﹤0.01% |
12,452
-89,780
| -88% | -$2.29M |
|
|
JMIA
3535
CALL
Jumia Technologies
JMIA
$726M
| $337K | ﹤0.01% |
+50,000
| New | +$315K |
|
|
FLIC
3536
DELISTED
First of Long Island Corp
FLIC
| $336K | ﹤0.01% |
13,408
+1,779
| +15% | +$42.4K |
|
|
PRSU
3537
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
| $336K | ﹤0.01% |
4,980
-146
| -3% | -$9.47K |
|
3538
HCI Group
HCI
$2.28B
| $335K | ﹤0.01% |
7,338
-100
| -1% | -$4.41K |
|
3539
Inseego
INSG
$108M
| $335K | ﹤0.01% |
+4,565
| New | +$263K |
|
3540
Arcus Biosciences
RCUS
$3.57B
| $334K | ﹤0.01% |
+33,100
| New | +$278K |
|
3541
Boise Cascade
BCC
$2.74B
| $332K | ﹤0.01% |
+9,089
| New | +$330K |
|
3542
PUT
Core Laboratories
CLB
$538M
| $331K | ﹤0.01% |
8,800
-64,900
| -88% | -$2.92M |
|
3543
ESCO Technologies
ESE
$8.49B
| $330K | ﹤0.01% |
3,569
+61
| +2% | +$5.2K |
|
3544
1st Source
SRCE
$2.07B
| $330K | ﹤0.01% |
6,352
-953
| -13% | -$47.9K |
|
3545
Genie Energy
GNE
$378M
| $328K | ﹤0.01% |
42,377
+16,300
| +63% | +$128K |
|
3546
CALL
Vodafone
VOD
$34.9B
| $327K | ﹤0.01% |
16,900
-60,000
| -78% | -$1.2M |
|
3547
Byline Bancorp
BY
$1.75B
| $326K | ﹤0.01% |
+16,649
| New | +$304K |
|
3548
Korro Bio
KRRO
$153M
| $325K | ﹤0.01% |
+371
| New | +$289K |
|
3549
REX American Resources
REX
$1.46B
| $324K | ﹤0.01% |
23,742
+546
| +2% | +$7.55K |
|
3550
National Beverage
FIZZ
$2.87B
| $323K | ﹤0.01% |
+12,648
| New | +$304K |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.